Cargando…

Size-Dependent Polymeric Nanoparticle Distribution in a Static versus Dynamic Microfluidic Blood Vessel Model: Implications for Nanoparticle-Based Drug Delivery

[Image: see text] Nanoparticles (NPs) have been widely investigated in the nanomedicine field. One of the main challenges is to accurately predict the NP distribution and fate after administration. Microfluidic platforms acquired huge importance as tools to model the in vivo environment. In this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gimondi, Sara, Ferreira, Helena, Reis, Rui L., Neves, Nuno M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189782/
https://www.ncbi.nlm.nih.gov/pubmed/37207132
http://dx.doi.org/10.1021/acsanm.3c00481
_version_ 1785043158828056576
author Gimondi, Sara
Ferreira, Helena
Reis, Rui L.
Neves, Nuno M.
author_facet Gimondi, Sara
Ferreira, Helena
Reis, Rui L.
Neves, Nuno M.
author_sort Gimondi, Sara
collection PubMed
description [Image: see text] Nanoparticles (NPs) have been widely investigated in the nanomedicine field. One of the main challenges is to accurately predict the NP distribution and fate after administration. Microfluidic platforms acquired huge importance as tools to model the in vivo environment. In this study, we leveraged a microfluidic platform to produce FITC-labeled poly(lactide-co-glycolide)-block-poly(ethylene glycol) (PLGA-PEG) NPs with defined sizes of 30, 50, and 70 nm. The study aimed to compare the ability of NPs with differences of 20 nm in size to cross an endothelial barrier using static (Transwell inserts) and dynamic (microfluidic perfusion device) in vitro models. Our results evidence a size-dependent NP crossing in both models (30 > 50 > 70 nm) and highlight the bias deriving from the static model, which does not involve shear stresses. The permeation of each NP size was significantly higher in the static system than in the dynamic model at the earliest stages. However, it gradually decreased to levels comparable with those of the dynamic model. Overall, this work highlights clear differences in NP distribution over time in static versus dynamic conditions and distinct size-dependent patterns. These findings reinforce the need for accurate in vitro screening models that allow for more accurate predictions of in vivo performance.
format Online
Article
Text
id pubmed-10189782
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-101897822023-05-18 Size-Dependent Polymeric Nanoparticle Distribution in a Static versus Dynamic Microfluidic Blood Vessel Model: Implications for Nanoparticle-Based Drug Delivery Gimondi, Sara Ferreira, Helena Reis, Rui L. Neves, Nuno M. ACS Appl Nano Mater [Image: see text] Nanoparticles (NPs) have been widely investigated in the nanomedicine field. One of the main challenges is to accurately predict the NP distribution and fate after administration. Microfluidic platforms acquired huge importance as tools to model the in vivo environment. In this study, we leveraged a microfluidic platform to produce FITC-labeled poly(lactide-co-glycolide)-block-poly(ethylene glycol) (PLGA-PEG) NPs with defined sizes of 30, 50, and 70 nm. The study aimed to compare the ability of NPs with differences of 20 nm in size to cross an endothelial barrier using static (Transwell inserts) and dynamic (microfluidic perfusion device) in vitro models. Our results evidence a size-dependent NP crossing in both models (30 > 50 > 70 nm) and highlight the bias deriving from the static model, which does not involve shear stresses. The permeation of each NP size was significantly higher in the static system than in the dynamic model at the earliest stages. However, it gradually decreased to levels comparable with those of the dynamic model. Overall, this work highlights clear differences in NP distribution over time in static versus dynamic conditions and distinct size-dependent patterns. These findings reinforce the need for accurate in vitro screening models that allow for more accurate predictions of in vivo performance. American Chemical Society 2023-04-24 /pmc/articles/PMC10189782/ /pubmed/37207132 http://dx.doi.org/10.1021/acsanm.3c00481 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by/4.0/Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Gimondi, Sara
Ferreira, Helena
Reis, Rui L.
Neves, Nuno M.
Size-Dependent Polymeric Nanoparticle Distribution in a Static versus Dynamic Microfluidic Blood Vessel Model: Implications for Nanoparticle-Based Drug Delivery
title Size-Dependent Polymeric Nanoparticle Distribution in a Static versus Dynamic Microfluidic Blood Vessel Model: Implications for Nanoparticle-Based Drug Delivery
title_full Size-Dependent Polymeric Nanoparticle Distribution in a Static versus Dynamic Microfluidic Blood Vessel Model: Implications for Nanoparticle-Based Drug Delivery
title_fullStr Size-Dependent Polymeric Nanoparticle Distribution in a Static versus Dynamic Microfluidic Blood Vessel Model: Implications for Nanoparticle-Based Drug Delivery
title_full_unstemmed Size-Dependent Polymeric Nanoparticle Distribution in a Static versus Dynamic Microfluidic Blood Vessel Model: Implications for Nanoparticle-Based Drug Delivery
title_short Size-Dependent Polymeric Nanoparticle Distribution in a Static versus Dynamic Microfluidic Blood Vessel Model: Implications for Nanoparticle-Based Drug Delivery
title_sort size-dependent polymeric nanoparticle distribution in a static versus dynamic microfluidic blood vessel model: implications for nanoparticle-based drug delivery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189782/
https://www.ncbi.nlm.nih.gov/pubmed/37207132
http://dx.doi.org/10.1021/acsanm.3c00481
work_keys_str_mv AT gimondisara sizedependentpolymericnanoparticledistributioninastaticversusdynamicmicrofluidicbloodvesselmodelimplicationsfornanoparticlebaseddrugdelivery
AT ferreirahelena sizedependentpolymericnanoparticledistributioninastaticversusdynamicmicrofluidicbloodvesselmodelimplicationsfornanoparticlebaseddrugdelivery
AT reisruil sizedependentpolymericnanoparticledistributioninastaticversusdynamicmicrofluidicbloodvesselmodelimplicationsfornanoparticlebaseddrugdelivery
AT nevesnunom sizedependentpolymericnanoparticledistributioninastaticversusdynamicmicrofluidicbloodvesselmodelimplicationsfornanoparticlebaseddrugdelivery